What is Yubo International Biotech Cash, Cash Equivalents, Marketable Securities?
Yubo International Biotech's quarterly cash, cash equivalents, marketable securities
stayed the same
from Jun. 2023 ($0.01 Mil) to Sep. 2023 ($0.01 Mil) but then
increased
from Sep. 2023 ($0.01 Mil) to Dec. 2023 ($0.01 Mil).
Yubo International Biotech's annual cash, cash equivalents, marketable securities
declined
from Dec. 2021 ($0.03 Mil) to Dec. 2022 ($0.02 Mil) and
declined
from Dec. 2022 ($0.02 Mil) to Dec. 2023 ($0.01 Mil).
Yubo International Biotech Cash, Cash Equivalents, Marketable Securities Historical Data
The historical data trend for Yubo International Biotech's Cash, Cash Equivalents, Marketable Securities can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Yubo International Biotech Cash, Cash Equivalents, Marketable Securities Chart
Yubo International Biotech Cash, Cash Equivalents, Marketable Securities Calculation
Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.
Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.
Yubo International Biotech (OTCPK:YBGJ) Cash, Cash Equivalents, Marketable Securities Explanation
Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.
A high number means either:
1) The company has competitive advantage generating lots of cash
2) Just sold a business or bonds (not necessarily good)
A low stockpile of cash usually means poor to mediocre economics.
There are 3 ways to create large cash reserve.
1) Sell new bonds or equity to public
2) Sell business or asset
3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)
When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.
Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.
Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.
Yubo International Biotech Cash, Cash Equivalents, Marketable Securities Related Terms
Thank you for viewing the detailed overview of Yubo International Biotech's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.
Yubo International Biotech (Yubo International Biotech) Business Description
Yubo International Biotech Ltd is a technology company focused on the research and development and application of endometrial stem cells. It offers products and services under the brand VIVCELL. Its product offerings include healthcare products for the respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products. It also offers stem cell-related services including cell testing and health management consulting services. The company derives its revenue from the sale of nebulizers containing frozen tubes with medical fluid and from the sale of oral liquids health products. The nebulizers are sold directly to consumers on its online e-commerce platform.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
YBGJ has been successfully added to your 